Table 2.
PF thickness, VAS, and 100-point scoring from pre-treatment to 4 weeks after treatment in patients who received ESWT and corticosteroid injections, respectively.
| 4 weeks after treatment | 4 weeks after treatment | ||||
|---|---|---|---|---|---|
| Baseline | ESWT | Baseline | Corticosteroid injections | p-value | |
| PF thickness | 0.37 ±0.07 | 0.46 ±0.08 | 0.38 ±0.06 | 0.43 ±0.09 | 0.048* |
| VAS | 6.23 ±1.11 | 3.40 ±1.08 | 6.24 ± 1.10 | 4.10 ±0.81 | 0.001** |
| 100-point scoring | 31.74 ±4.61 | 72.11 ±11.09 | 31.84 ±4.44 | 70.38 ±8.55 | 0.391 |
| Pain Scores | 21.51 ±4.17 | 52.94 ±9.25 | 21.60 ±4.27 | 51.66 ±7.90 | 0.466 |
| Functional Scores | 10.23 ±2.26 | 19.17 ±3.45 | 10.24 ±1.52 | 18.72 ±1.49 | 0.401 |
PF: plantar fascia. VAS: 10-point visual analogue scale. ESWT: extracorporeal shock wave therapy. Mann-Whitney u test for comparison of the thickness of the plantar fascia and pain scores ESWT and CSI group for p-value.
**
: p<0.01,
*
: p<0.05.